Advertisement

Advertisement

CMMB Stock Latest News

Chemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall

Company AnnouncementsChemomab Adjourns April 28 Shareholder Meeting to May 5 After Quorum Shortfall

Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters

PremiumCompany Announcements

Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance Matters

2M ago

Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data

PremiumCompany Announcements

Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data

2M ago

Chemomab Therapeutics sees cash runway through 1Q27

PremiumThe Fly

Chemomab Therapeutics sees cash runway through 1Q27

2M ago

Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year

PremiumThe Fly

Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year

2M ago

Chemomab Therapeutics announces results of its Phase 2 SPRING trial

PremiumThe FlyChemomab Therapeutics announces results of its Phase 2 SPRING trial

5M ago

Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial

Company Announcements

Chemomab Therapeutics Advances PSC Treatment with Phase 3 Trial

5M ago

Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support

Company Announcements

Chemomab Therapeutics Advances Nebokitug Phase 3 Trial with Regulatory Support

6M ago

Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year

PremiumThe Fly

Chemomab Therapeutics reports Q3 EPS (0.4c) vs (1c) last year

6M ago

Chemomab announces presentations at AASLD 2025 on nebokitug data

PremiumThe Fly

Chemomab announces presentations at AASLD 2025 on nebokitug data

6M ago

CMMB Earnings this Week: How Will it Perform?

PremiumPre-Earnings

CMMB Earnings this Week: How Will it Perform?

6M ago

Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug

PremiumCompany Announcements

Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug

8M ago

Chemomab Therapeutics management to meet with Maxim

PremiumThe FlyChemomab Therapeutics management to meet with Maxim

8M ago

Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer

The Fly

Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer

8M ago

Chemomab Therapeutics Ltd – ADR trading halted, news pending

The Fly

Chemomab Therapeutics Ltd – ADR trading halted, news pending

8M ago

Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested

PremiumMarket News

Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested

8M ago

Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025

PremiumCompany Announcements

Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025

9M ago

Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support

PremiumRatings

Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support

9M ago

Chemomab Therapeutics Reports Q2 2025 Financial Results

PremiumCompany Announcements

Chemomab Therapeutics Reports Q2 2025 Financial Results

9M ago

Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year

PremiumThe FlyChemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year

9M ago

Chemomab Therapeutics management to meet with Maxim

The Fly

Chemomab Therapeutics management to meet with Maxim

9M ago

Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital

Company Announcements

Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >